HRT Financial’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-330,661
Closed -$3.02M 3555
2025
Q2
$3.02M Buy
330,661
+180,342
+120% +$1.33M 0.01% 747
2025
Q1
$1.2M Sell
150,319
-508
-0.3% -$3.72K 0.01% 1044
2024
Q4
$818K Sell
150,827
-21,224
-12% -$130K ﹤0.01% 1180
2024
Q3
$1.24M Buy
172,051
+52,719
+44% +$483K 0.01% 1124
2024
Q2
$1.29M Buy
+119,332
New +$1.53M 0.01% 898
2024
Q1
Sell
-66,244
Closed -$1.44M 2988
2023
Q4
$1.44M Buy
+66,244
New +$1.31M 0.01% 814
2023
Q3
Sell
-16,892
Closed -$794K 3003
2023
Q2
$794K Sell
16,892
-20,180
-54% -$1M 0.01% 1091
2023
Q1
$1.55M Buy
37,072
+16,522
+80% +$710K 0.02% 727
2022
Q4
$783K Buy
20,550
+6,885
+50% +$263K 0.01% 1115
2022
Q3
$535K Buy
+13,665
New +$528K 0.01% 1392
2022
Q2
Sell
-19,319
Closed -$639K 3627
2022
Q1
$639K Sell
19,319
-5,255
-21% -$198K ﹤0.01% 1454
2021
Q4
$1.04M Sell
24,574
-772
-3% -$32.3K 0.01% 1072
2021
Q3
$1.12M Buy
+25,346
New +$1.16M 0.01% 1154
2021
Q2
Sell
-10,640
Closed -$796K 3447
2021
Q1
$796K Buy
10,640
+2,988
+39% +$245K 0.01% 1362
2020
Q4
$661K Sell
7,652
-21,113
-73% -$1.56M 0.01% 876
2020
Q3
$1.76M Buy
28,765
+13,262
+86% +$672K 0.05% 292
2020
Q2
$644K Buy
+15,503
New +$563K 0.02% 690
2019
Q4
Sell
-2,228
Closed -$312K 1569
2019
Q3
$312K Buy
+2,228
New +$373K 0.01% 916
2018
Q3
Sell
-3,200
Closed -$500K 482
2018
Q2
$500K Buy
+3,200
New +$502K 0.18% 100

Other funds holding SAGE